CA2550753A1 - Liquid vitamin and supplement formulations - Google Patents

Liquid vitamin and supplement formulations Download PDF

Info

Publication number
CA2550753A1
CA2550753A1 CA002550753A CA2550753A CA2550753A1 CA 2550753 A1 CA2550753 A1 CA 2550753A1 CA 002550753 A CA002550753 A CA 002550753A CA 2550753 A CA2550753 A CA 2550753A CA 2550753 A1 CA2550753 A1 CA 2550753A1
Authority
CA
Canada
Prior art keywords
amount
vitamin
present
liquid
liquid formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002550753A
Other languages
French (fr)
Inventor
Carl Milson
Shane Carr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A TOUCH OF LOVE Inc
Original Assignee
A TOUCH OF LOVE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A TOUCH OF LOVE Inc filed Critical A TOUCH OF LOVE Inc
Priority to CA002550753A priority Critical patent/CA2550753A1/en
Publication of CA2550753A1 publication Critical patent/CA2550753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)

Abstract

A liquid vitamin or multi-vitamin supplement composition comprising (a) a first liquid vitamin formulation comprising glucosamine sulfate, devils claw root alcohol extract , cats claw bark alcohol extract, water, glycerine, ascorbic acid, citric acid, sodium benzoate and potassium sorbate and (b) a second liquid vitamin formulation comprising vitamins A, B1, B2, B3, B5, B 6, B9, B12, C, D3 and E, beta-carotene, water, citric acid, xanthan gum, ascorbic acid, potassium sorbate and sodium benzoate, wherein the two formulations are separate solutions.

Description

I

LIQUID VITAMIN AND SUPPLEMENT FORMULATIONS

FIELD OF THE INVENTION

This invention relates to, in general, a liquid vitamin composition, and in particular to a composition comprising two separate liquid vitamin formulations.

Generally speaking, vitamins, multi-vitamins or supplements can be introduced to pets and humans to supplement the diet thereof. One way in which this can be introduced is through pills or tablets, which contain the vitamins, multi-vitamins or supplements in solid form.

11 Alternatively, it is well known that liquids are absorbed faster and more effectively into the body than solids. For example, studies have shown that the body utilizes only about 20% of a pill's components, while, in some cases, 98% of ingested liquid can be absorbed.
Further, vitamins, multi-vitamins or supplements in solid form can be highly processed and, as such, may lack in many vitamins, these being refined out or diluted during the processing stage.

Thus, there is a need for an improved liquid vitamin or multi-vitamin supplement composition that allows for easy absorption of the vitamins, and which results in minimum loss in the quantity and quality of the vitamins. In this regard, the present invention substantially fulfills this need.

SUMMARY OF THE INVENTION

Accordingly, one object of the present invention is to provide an improved liquid vitamin or multi-vitamin composition that allows for easy absorption of the vitamins, and which results in 26 minimum loss in the quantity and quality of the vitamins.

1 Another object of the present invention is to provide an improved liquid vitamin or multi-vitamin supplement composition comprising two separate liquid formulations.

According to one aspect of the present invention, there is provided a liquid vitamin composition comprising (a) a first liquid formulation comprising glucosamine sulfate, devils claw 6 root alcohol extract, cats claw bark alcohol extract, water, glycerine, ascorbic acid, citric acid, sodium benzoate and potassium sorbate; and (b) a second liquid formulation comprising vitamins A, B1, B2, B3, B5, B6, B9, B12, C, D3 and E, beta-carotene, water, citric acid, xanthan gum, ascorbic acid, potassium sorbate and sodium benzoate, characterized in that the first and the second liquid formulation are separate solutions.

According to another aspect of the present invention, there is provided a liquid composition comprising (a) a first liquid formulation comprising glucosamine sulfate, devils claw root alcohol extract, cats claw bark alcohol extract, water, glycerine, ascorbic acid, citric acid, sodium benzoate and potassium sorbate, wherein, in a 500 ml formulation of the first liquid formulation, glucosamine 16 sulfate is present in an amount of 16.66 grams, devils claw root alcohol extract is present in an amount of 25 grams, and cats claw bark alcohol extract is present in an amount of 20 grams; and (b) a second liquid formulation comprising vitamins A, B1, B2, B3, B5, B6, B9, B12, C, D3 and E, beta-carotene, water, citric acid, xanthan gum, ascorbic acid, potassium sorbate and sodium benzoate, wherein, in a 250 ml formulation of the second liquid formulation, vitamin B1 in is present in an 21 amount of 1.5 mg, vitamin B2 is present in an amount of 1.66 mg, vitamin B3 is present in an amount of 15.0 mg, vitamin B5 is present in an amount of12.5 mg, vitamin B6 is present in an amount of 1.0 mg, vitamin B9 is present in an amount of 01. mg, vitamin C is present in an amount of 50.0 mg, vitamin D3 is present in an amount of 200.0 U.I., vitamin E is present in an amount of 8.0 U.I., vitamin A is present in an amount of 1128.0 U.I., and Beta-carotene is present in an amount 26 of 1666.0 U.1, and wherein the first liquid formulation and the second liquid formulation are separate solutions.

The advantage of the present invention is that it provides an improved liquid vitamin or multi-
2 I

1 vitamin composition that allows for easy absorption of the vitamins, and which results in minimum loss in the quantity and quality of the vitamins.

A further advantage of the present invention is that it provides an improved liquid vitamin or multi-vitamin supplement composition comprising two separate liquid formulations.

DESCRIPTION OF THE PREFERRED EMBODIMENT

The compositions herein are adapted for use by a companion animal. In this respect, as will be well-understood by the ordinarily skilled artisan, the primary use of the compositions described 11 herein are for companion animal use and the compositions are therefore formulated as such, though it is conceivable that these compositions could also be safely used for human use.

The present invention relates to liquid vitamin or supplement compositions that are useful for relief and treatment of various conditions in animals. Preparation of a stable liquid composition with 16 one or more vitamins or supplements that may optionally be admixed with an animal's food or water allows the owner of the animal to administer effective and metered quantities thereof on an "as needed" basis, such as daily, weekly or monthly.

21 Accordingly, the present invention provides a liquid vitamin composition comprising (a) a first liquid vitamin formulation comprising glucosamine sulfate, devils claw root alcohol extract, cats claw bark alcohol extract, water, glycerine, ascorbic acid, citric acid, sodium benzoate and potassium sorbate; and (b) a second liquid vitamin formulation comprising vitamins A, B1, B2, B3, B5, B6, B9, B12, C, D3 and E, beta-carotene, water, citric acid, xanthan gum, ascorbic acid, potassium sorbate 26 and sodium benzoate, characterized in that the two formulations are separate solutions.

The liquid composition of the present invention provides the advantage over the prior art in that the two separate vitamin formulations are in the liquid form, and, as noted previously, liquids are absorbed faster and more effectively into the body than solids. The composition may, if desired, be
3 1 accommodated in a single container with two distinct compartments.
Alternatively, the composition may be provided in two separate containers comprised within a common pack or packaging system which is appropriate for sale or delivery or merchandising. The container(s) may be of any size as appropriate for the required need and destination.

6 The liquid composition comprises a first liquid formulation comprising glucosamine sulfate, devils claw root alcohol extract, cats claw bark alcohol extract, water, glycerine, ascorbic acid, citric acid, sodium benzoate and potassium sorbate. The concentration of each of these in the first liquid formulation may be varied. A flavorant may also be used to increase palatability of the compositions of the current invention. In a preferred embodiment, a flavorant such as apple flavor could be used 11 with respect to the first liquid formulation, and a flavorant such as natural peach flavor could be used with respect to the second liquid formulation. The liquid compositions of the current invention may comprise a range from about 0.00001% to about 99% flavorant, from about 0.
0001% to about 75%
flavorant, from about 0.001 to about 50% flavorant, from about 0.01 to about 30% flavorant, from about 0. 1% to about 20% flavorant, from about 1% to about 10% flavorant, from about 2% to about 16 6% flavorant, from about 3% to about 5% flavorant, all by weight of the composition.

The first liquid formulation is suitably in the aqueous phase, and, with respect to water, the first liquid composition further comprises at least about 50% water, by weight of the composition.
21 Suitably, in a 500 ml formulation of the first liquid formulation, glucosamine sulfate is present in the first liquid formulation in an amount of 16.66 grams, devils claw root alcohol extract is present in an amount of 25 grams, and cats claw bark alcohol extract is present in an amount of 20 grams. The benefits of using glucosamine sulfate is that it stimulates the production of synovial fluid, which lubricates the joints. Without enough of this fluid, the cartilage in the joint begins to deteriorate and 26 harden, causing wear and tear on the joints, which leads to arthritis.

The first liquid formulation further comprises an antioxidant. The preferred antioxidants are
4 1 citric acid and ascorbic acid. The first liquid formulation may also further comprise a stabilizing agent and/or an anti-gelling agent. Examples of such suitable stabilizing agents include inorganic salts such as potassium sorbate, sorbitol, propane 1,2 diol and glycerine. With respect to the present invention, the preferred agents that are utilized are potassium sorbate and glycerine.

The second liquid vitamin formulation of the present invention comprises a mixture of vitamins A, B1, B2, B3, B5, B6, B9, B12, C, D3 and E, beta-carotene, water, citric acid, xanthan gum, ascorbic acid, potassium sorbate and sodium benzoate. It is preferred that this formulation is also in the aqueous phase, and, with respect to water, the second liquid composition further comprises 11 at least about 50% water, by weight of the composition.

The concentration of each vitamin in the second liquid formulation also may be varied.
Suitably, in a 250 ml formulation of the second liquid formulation, vitamin B1 is present in an 16 amount of 1.5 mg; vitamin B2 is present in an amount of 1.66 mg; vitamin B3 is present in an amount of 15.0 mg; vitamin B5 is present in an amount ofl2.5 mg; vitamin B6 is present in an amount of 1.0 mg; vitamin B9 is present in an amount suitably of 01. mg. Further, vitamin C
is present in an amount of 50.0 mg, vitamin D3 is present in an amount of 200.0 U.I., and vitamin E is present in an amount of 8.0 U.I.. Vitamin A is present in an amount of 1128.0 U.I., and Beta-carotene is present 21 in an amount of 1666.0 U.I.

The second liquid formulation further comprises an antioxidant. The preferred antioxidants are citric acid and ascorbic acid. The second liquid formulation may also further comprise a 26 stabilizing agent and/or an anti-gelling agent.. With respect to the present invention, the preferred agent that is utilized is potassium sorbate, though it is conceivable that other types could be used, examples of such suitable stabilizing agents being sorbitol, propane 1,2 diol and glycerine.

31 The second liquid formulation, in a preferred embodiment, further comprises a suspension 1 agent. The preferred suspension agent is xanthan gum, though other variations could be used, which could include polysaccharides such as sugars and carageenan.

As noted previously, the liquid formulations of the present invention can be introduced into the diet of the animal by, for example, adding the liquid composition to the animal's food and water.

The present invention has been described herein with regard to preferred embodiments.
However, it will be obvious to persons skilled in the art that a number of variations and modifications can be made without departing from the scope of the invention as described herein.

Claims (9)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE PROPERTY OR
PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A liquid composition comprising (a) a first liquid formulation comprising glucosamine sulfate, devils claw root alcohol extract, cats claw bark alcohol extract, water, glycerine, ascorbic acid, citric acid, sodium benzoate and potassium sorbate; and (b) a second liquid formulation comprising vitamins A, B1, B2, B3, B5, B6, B9, B12, C, D3 and E, beta-carotene, water, citric acid, xanthan gum, ascorbic acid, potassium sorbate and sodium benzoate, characterized in that the first and the second liquid formulation are separate solutions.
2. The liquid composition as claimed in claim 1 in which the first and the second liquid formulation are accommodated in a single container with two distinct compartments or are accommodated in two separate containers in a common pack or common packaging system.
3. The liquid composition as claimed in claim 1, wherein in the first liquid formulation is in the aqueous phase.
4. The liquid composition as claimed in claim 1, wherein in the second liquid formulation is in the aqueous phase.
5. The liquid composition as claimed in claim 1, wherein the first and the second liquid formulation comprise at least about 50% water, by weight of the composition.
6. The liquid composition as claimed in claim 1, wherein the the first and the second liquid formulation further comprise a flavorant.
7. The liquid composition as claimed in claim 1, wherein the first liquid formulation comprises, in a 500 ml formulation of the first liquid formulation, glucosamine sulfate in an amount of 16.66 grams, devils claw root alcohol extract in an amount of 25 grams, and cats claw bark alcohol extract in an amount of 20 grams.
8. The liquid composition as claimed in claim 1, wherein the second liquid formulation comprises, in a 250 ml formulation of the second liquid formulation, vitamin B1 in an amount of 1.5 mg, vitamin B2 in an amount of 1.66 mg, vitamin B3 in an amount of 15.0 mg, vitamin B5 in an amount of12.5 mg, vitamin B6 in an amount of 1.0 mg, vitamin B9 in an amount of 01. mg, vitamin C in an amount of 50.0 mg, vitamin D3 in an amount of 200.0 U.I., vitamin E in an amount of 8.0 U.I., vitamin A in an amount of 1128.0 U.I., and Beta-carotene in an amount of 1666.0 U.I.
9. A liquid composition comprising (a) a first liquid formulation comprising glucosamine sulfate, devils claw root alcohol extract, cats claw bark alcohol extract, water, glycerine, ascorbic acid, citric acid, sodium benzoate and potassium sorbate, wherein, in a 500 ml formulation of the first liquid formulation, glucosamine sulfate is present in an amount of 16.66 grams, devils claw root alcohol extract is present in an amount of 25 grams, and cats claw bark alcohol extract is present in an amount of 20 grams; and (b) a second liquid formulation comprising vitamins A, B1, B2, B3, B5, B6, B9, B12, C, D3 and E, beta-carotene, water, citric acid, xanthan gum, ascorbic acid, potassium sorbate and sodium benzoate, wherein, in a 250 ml formulation of the second liquid formulation, vitamin B1 in is present in an amount of 1.5 mg, vitamin B2 is present in an amount of 1.66 mg, vitamin B3 is present in an amount of 15.0 mg, vitamin B5 is present in an amount of12.5 mg, vitamin B6 is present in an amount of 1.0 mg, vitamin B9 is present in an amount of 01. mg, vitamin C is present in an amount of 50.0 mg, vitamin D3 is present in an amount of 200.0 U.I., vitamin E is present in an amount of 8.0 U.I., vitamin A is present in an amount of 1128.0 U.I., and Beta-carotene is present in an amount of 1666.0 U.I, and wherein the first liquid formulation and the second liquid formulation are separate solutions.
CA002550753A 2006-06-21 2006-06-21 Liquid vitamin and supplement formulations Abandoned CA2550753A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002550753A CA2550753A1 (en) 2006-06-21 2006-06-21 Liquid vitamin and supplement formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002550753A CA2550753A1 (en) 2006-06-21 2006-06-21 Liquid vitamin and supplement formulations

Publications (1)

Publication Number Publication Date
CA2550753A1 true CA2550753A1 (en) 2007-12-21

Family

ID=38830215

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002550753A Abandoned CA2550753A1 (en) 2006-06-21 2006-06-21 Liquid vitamin and supplement formulations

Country Status (1)

Country Link
CA (1) CA2550753A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397136A1 (en) * 2010-06-17 2011-12-21 Sp2L Anti-inflammatory composition
EP2460518A1 (en) * 2010-12-02 2012-06-06 Sp2L Composition including a chondroprotective agent and vitamins

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397136A1 (en) * 2010-06-17 2011-12-21 Sp2L Anti-inflammatory composition
FR2961401A1 (en) * 2010-06-17 2011-12-23 Laetitia Mathez ANTI-INFLAMMATORY COMPOSITION
EP2460518A1 (en) * 2010-12-02 2012-06-06 Sp2L Composition including a chondroprotective agent and vitamins

Similar Documents

Publication Publication Date Title
EP1838166B1 (en) Compositions and methods for improving kidney function
US8012513B2 (en) Method for promoting eye health
EP2023945B1 (en) Composition for improving eye health
US8911770B2 (en) Dissolvable dietary supplement strip and methods for using the same
DK2387325T3 (en) Methods for improving liver and immune function in an animal
ZA200603603B (en) Fluid composition for increased total water intake
US20150164825A1 (en) Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
CN112367848A (en) Composition for supporting an animal with cancer
CA2550753A1 (en) Liquid vitamin and supplement formulations
JP6742575B2 (en) Joint function improving composition
Shitole et al. A review on: Preservatives used in pharmaceuticals and impacts on health
US20220323535A1 (en) Health supplement
US7964225B1 (en) Tear stain management compositions and methods
US20240091289A1 (en) Lichen Extract-based Formulation for Cervids
JPH1156299A (en) Processed food containing vitamins
US10016357B2 (en) Personal lubricants
JP6744673B2 (en) Joint function improving composition
JP7466942B2 (en) Oral Compositions
US20210128493A1 (en) Pet Food Supplement
Ershoff et al. An Unidentified Water-Soluble Factor in Alfalfa Which Improves Utilization of Vitamin A
GB2549585A (en) Animal foodstuff and method of manufacture thereof
de Goes et al. Dry matter intake of steers supplemented with crambe crushed, in total replacement of soybean meal.
CH704065A1 (en) Liquid dietary supplement.
CZ15507U1 (en) Special vitamin-mineral composition for sows and packaging thereof

Legal Events

Date Code Title Description
FZDE Dead